The global Ophthalmology AMD market size was valued at US$ 8.45 billion in 2024 and is projected to reach US$ 12.6 billion by 2030, at a CAGR of 6.9%
The United States Ophthalmology AMD market size was valued at US$ 2.85 billion in 2024 and is projected to reach US$ 4.35 billion by 2030, at a CAGR of 7.3%
Medical treatments for age-related macular degeneration. Products require extensive clinical validation. Treatments undergo rigorous testing.
Medical treatment leads with 88% share. Clinical precision at 100%. Regulatory compliance achieved 100%. Research efficiency improved 35%. Applications: wet AMD (65%), dry AMD (25%), research (10%). Clinical innovations enhanced efficacy 30%. North America leads with 45% share. Advanced therapies grew 42%. Healthcare partnerships increased 48%. Quality systems represent 25% of costs. Innovation focuses on biologics. Aging population drives 45% growth.
Report Overview
Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected. Age-related macular degeneration is a progressive condition, and it is common among the geriatric population. The growing geriatric population is contributing to the rising incidence of age-related macular degeneration globally. As a result, there is a high demand for therapeutics to treat the condition. Pharmaceutical companies are leveraging this opportunity and are focusing on releasing drugs to treat age-related macular degeneration.
This report provides a deep insight into the global Ophthalmology for Age-related Macular Degeneration Diseases market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Ophthalmology for Age-related Macular Degeneration Diseases Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Ophthalmology for Age-related Macular Degeneration Diseases market in any manner.
Global Ophthalmology for Age-related Macular Degeneration Diseases Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
DaVinci
Magnifying America
Freedom Scientific
LVI Low Vision International
NuEyes
Canadian Assistive Technologies
Merlin Ultra
HumanWare
Eschenbach Optik GmbH
Vispero
Esight
Rejoin Technology
Quantum
Market Segmentation (by Type)
Portable
Desktop
Market Segmentation (by Application)
Wet AMD
Dry AMD
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Ophthalmology for Age-related Macular Degeneration Diseases Market
Overview of the regional outlook of the Ophthalmology for Age-related Macular Degeneration Diseases Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Ophthalmology for Age-related Macular Degeneration Diseases
1.2 Key Market Segments
1.2.1 Ophthalmology for Age-related Macular Degeneration Diseases Segment by Type
1.2.2 Ophthalmology for Age-related Macular Degeneration Diseases Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Ophthalmology for Age-related Macular Degeneration Diseases Market Overview
2.1 Global Market Overview
2.1.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Ophthalmology for Age-related Macular Degeneration Diseases Market Competitive Landscape
3.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales by Manufacturers (2019-2025)
3.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Revenue Market Share by Manufacturers (2019-2025)
3.3 Ophthalmology for Age-related Macular Degeneration Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Ophthalmology for Age-related Macular Degeneration Diseases Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Ophthalmology for Age-related Macular Degeneration Diseases Sales Sites, Area Served, Product Type
3.6 Ophthalmology for Age-related Macular Degeneration Diseases Market Competitive Situation and Trends
3.6.1 Ophthalmology for Age-related Macular Degeneration Diseases Market Concentration Rate
3.6.2 Global 5 and 10 Largest Ophthalmology for Age-related Macular Degeneration Diseases Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Ophthalmology for Age-related Macular Degeneration Diseases Industry Chain Analysis
4.1 Ophthalmology for Age-related Macular Degeneration Diseases Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Ophthalmology for Age-related Macular Degeneration Diseases Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Ophthalmology for Age-related Macular Degeneration Diseases Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Type (2019-2025)
6.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size Market Share by Type (2019-2025)
6.4 Global Ophthalmology for Age-related Macular Degeneration Diseases Price by Type (2019-2025)
7 Ophthalmology for Age-related Macular Degeneration Diseases Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Sales by Application (2019-2025)
7.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size (M USD) by Application (2019-2025)
7.4 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Growth Rate by Application (2019-2025)
8 Ophthalmology for Age-related Macular Degeneration Diseases Market Segmentation by Region
8.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales by Region
8.1.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales by Region
8.1.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Region
8.2 North America
8.2.1 North America Ophthalmology for Age-related Macular Degeneration Diseases Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Ophthalmology for Age-related Macular Degeneration Diseases Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Ophthalmology for Age-related Macular Degeneration Diseases Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Ophthalmology for Age-related Macular Degeneration Diseases Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Ophthalmology for Age-related Macular Degeneration Diseases Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 DaVinci
9.1.1 DaVinci Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
9.1.2 DaVinci Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
9.1.3 DaVinci Ophthalmology for Age-related Macular Degeneration Diseases Product Market Performance
9.1.4 DaVinci Business Overview
9.1.5 DaVinci Ophthalmology for Age-related Macular Degeneration Diseases SWOT Analysis
9.1.6 DaVinci Recent Developments
9.2 Magnifying America
9.2.1 Magnifying America Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
9.2.2 Magnifying America Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
9.2.3 Magnifying America Ophthalmology for Age-related Macular Degeneration Diseases Product Market Performance
9.2.4 Magnifying America Business Overview
9.2.5 Magnifying America Ophthalmology for Age-related Macular Degeneration Diseases SWOT Analysis
9.2.6 Magnifying America Recent Developments
9.3 Freedom Scientific
9.3.1 Freedom Scientific Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
9.3.2 Freedom Scientific Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
9.3.3 Freedom Scientific Ophthalmology for Age-related Macular Degeneration Diseases Product Market Performance
9.3.4 Freedom Scientific Ophthalmology for Age-related Macular Degeneration Diseases SWOT Analysis
9.3.5 Freedom Scientific Business Overview
9.3.6 Freedom Scientific Recent Developments
9.4 LVI Low Vision International
9.4.1 LVI Low Vision International Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
9.4.2 LVI Low Vision International Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
9.4.3 LVI Low Vision International Ophthalmology for Age-related Macular Degeneration Diseases Product Market Performance
9.4.4 LVI Low Vision International Business Overview
9.4.5 LVI Low Vision International Recent Developments
9.5 NuEyes
9.5.1 NuEyes Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
9.5.2 NuEyes Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
9.5.3 NuEyes Ophthalmology for Age-related Macular Degeneration Diseases Product Market Performance
9.5.4 NuEyes Business Overview
9.5.5 NuEyes Recent Developments
9.6 Canadian Assistive Technologies
9.6.1 Canadian Assistive Technologies Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
9.6.2 Canadian Assistive Technologies Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
9.6.3 Canadian Assistive Technologies Ophthalmology for Age-related Macular Degeneration Diseases Product Market Performance
9.6.4 Canadian Assistive Technologies Business Overview
9.6.5 Canadian Assistive Technologies Recent Developments
9.7 Merlin Ultra
9.7.1 Merlin Ultra Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
9.7.2 Merlin Ultra Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
9.7.3 Merlin Ultra Ophthalmology for Age-related Macular Degeneration Diseases Product Market Performance
9.7.4 Merlin Ultra Business Overview
9.7.5 Merlin Ultra Recent Developments
9.8 HumanWare
9.8.1 HumanWare Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
9.8.2 HumanWare Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
9.8.3 HumanWare Ophthalmology for Age-related Macular Degeneration Diseases Product Market Performance
9.8.4 HumanWare Business Overview
9.8.5 HumanWare Recent Developments
9.9 Eschenbach Optik GmbH
9.9.1 Eschenbach Optik GmbH Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
9.9.2 Eschenbach Optik GmbH Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
9.9.3 Eschenbach Optik GmbH Ophthalmology for Age-related Macular Degeneration Diseases Product Market Performance
9.9.4 Eschenbach Optik GmbH Business Overview
9.9.5 Eschenbach Optik GmbH Recent Developments
9.10 Vispero
9.10.1 Vispero Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
9.10.2 Vispero Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
9.10.3 Vispero Ophthalmology for Age-related Macular Degeneration Diseases Product Market Performance
9.10.4 Vispero Business Overview
9.10.5 Vispero Recent Developments
9.11 Esight
9.11.1 Esight Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
9.11.2 Esight Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
9.11.3 Esight Ophthalmology for Age-related Macular Degeneration Diseases Product Market Performance
9.11.4 Esight Business Overview
9.11.5 Esight Recent Developments
9.12 Rejoin Technology
9.12.1 Rejoin Technology Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
9.12.2 Rejoin Technology Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
9.12.3 Rejoin Technology Ophthalmology for Age-related Macular Degeneration Diseases Product Market Performance
9.12.4 Rejoin Technology Business Overview
9.12.5 Rejoin Technology Recent Developments
9.13 Quantum
9.13.1 Quantum Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
9.13.2 Quantum Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
9.13.3 Quantum Ophthalmology for Age-related Macular Degeneration Diseases Product Market Performance
9.13.4 Quantum Business Overview
9.13.5 Quantum Recent Developments
10 Ophthalmology for Age-related Macular Degeneration Diseases Market Forecast by Region
10.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast
10.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast by Country
10.2.3 Asia Pacific Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast by Region
10.2.4 South America Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Ophthalmology for Age-related Macular Degeneration Diseases by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Ophthalmology for Age-related Macular Degeneration Diseases by Type (2025-2030)
11.1.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Ophthalmology for Age-related Macular Degeneration Diseases by Type (2025-2030)
11.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Forecast by Application (2025-2030)
11.2.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units) Forecast by Application
11.2.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Ophthalmology for Age-related Macular Degeneration Diseases Market Size Comparison by Region (M USD)
Table 5. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Ophthalmology for Age-related Macular Degeneration Diseases Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Ophthalmology for Age-related Macular Degeneration Diseases Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmology for Age-related Macular Degeneration Diseases as of 2022)
Table 10. Global Market Ophthalmology for Age-related Macular Degeneration Diseases Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Ophthalmology for Age-related Macular Degeneration Diseases Sales Sites and Area Served
Table 12. Manufacturers Ophthalmology for Age-related Macular Degeneration Diseases Product Type
Table 13. Global Ophthalmology for Age-related Macular Degeneration Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Ophthalmology for Age-related Macular Degeneration Diseases
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Ophthalmology for Age-related Macular Degeneration Diseases Market Challenges
Table 22. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales by Type (K Units)
Table 23. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size by Type (M USD)
Table 24. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units) by Type (2019-2025)
Table 25. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Type (2019-2025)
Table 26. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size (M USD) by Type (2019-2025)
Table 27. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size Share by Type (2019-2025)
Table 28. Global Ophthalmology for Age-related Macular Degeneration Diseases Price (USD/Unit) by Type (2019-2025)
Table 29. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units) by Application
Table 30. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size by Application
Table 31. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales by Application (2019-2025) & (K Units)
Table 32. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Application (2019-2025)
Table 33. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales by Application (2019-2025) & (M USD)
Table 34. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Share by Application (2019-2025)
Table 35. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Growth Rate by Application (2019-2025)
Table 36. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales by Region (2019-2025) & (K Units)
Table 37. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Region (2019-2025)
Table 38. North America Ophthalmology for Age-related Macular Degeneration Diseases Sales by Country (2019-2025) & (K Units)
Table 39. Europe Ophthalmology for Age-related Macular Degeneration Diseases Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Ophthalmology for Age-related Macular Degeneration Diseases Sales by Region (2019-2025) & (K Units)
Table 41. South America Ophthalmology for Age-related Macular Degeneration Diseases Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Ophthalmology for Age-related Macular Degeneration Diseases Sales by Region (2019-2025) & (K Units)
Table 43. DaVinci Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
Table 44. DaVinci Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
Table 45. DaVinci Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 46. DaVinci Business Overview
Table 47. DaVinci Ophthalmology for Age-related Macular Degeneration Diseases SWOT Analysis
Table 48. DaVinci Recent Developments
Table 49. Magnifying America Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
Table 50. Magnifying America Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
Table 51. Magnifying America Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 52. Magnifying America Business Overview
Table 53. Magnifying America Ophthalmology for Age-related Macular Degeneration Diseases SWOT Analysis
Table 54. Magnifying America Recent Developments
Table 55. Freedom Scientific Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
Table 56. Freedom Scientific Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
Table 57. Freedom Scientific Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 58. Freedom Scientific Ophthalmology for Age-related Macular Degeneration Diseases SWOT Analysis
Table 59. Freedom Scientific Business Overview
Table 60. Freedom Scientific Recent Developments
Table 61. LVI Low Vision International Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
Table 62. LVI Low Vision International Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
Table 63. LVI Low Vision International Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 64. LVI Low Vision International Business Overview
Table 65. LVI Low Vision International Recent Developments
Table 66. NuEyes Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
Table 67. NuEyes Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
Table 68. NuEyes Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 69. NuEyes Business Overview
Table 70. NuEyes Recent Developments
Table 71. Canadian Assistive Technologies Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
Table 72. Canadian Assistive Technologies Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
Table 73. Canadian Assistive Technologies Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 74. Canadian Assistive Technologies Business Overview
Table 75. Canadian Assistive Technologies Recent Developments
Table 76. Merlin Ultra Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
Table 77. Merlin Ultra Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
Table 78. Merlin Ultra Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 79. Merlin Ultra Business Overview
Table 80. Merlin Ultra Recent Developments
Table 81. HumanWare Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
Table 82. HumanWare Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
Table 83. HumanWare Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 84. HumanWare Business Overview
Table 85. HumanWare Recent Developments
Table 86. Eschenbach Optik GmbH Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
Table 87. Eschenbach Optik GmbH Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
Table 88. Eschenbach Optik GmbH Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 89. Eschenbach Optik GmbH Business Overview
Table 90. Eschenbach Optik GmbH Recent Developments
Table 91. Vispero Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
Table 92. Vispero Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
Table 93. Vispero Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 94. Vispero Business Overview
Table 95. Vispero Recent Developments
Table 96. Esight Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
Table 97. Esight Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
Table 98. Esight Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 99. Esight Business Overview
Table 100. Esight Recent Developments
Table 101. Rejoin Technology Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
Table 102. Rejoin Technology Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
Table 103. Rejoin Technology Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 104. Rejoin Technology Business Overview
Table 105. Rejoin Technology Recent Developments
Table 106. Quantum Ophthalmology for Age-related Macular Degeneration Diseases Basic Information
Table 107. Quantum Ophthalmology for Age-related Macular Degeneration Diseases Product Overview
Table 108. Quantum Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 109. Quantum Business Overview
Table 110. Quantum Recent Developments
Table 111. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Ophthalmology for Age-related Macular Degeneration Diseases Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Ophthalmology for Age-related Macular Degeneration Diseases Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Ophthalmology for Age-related Macular Degeneration Diseases Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Ophthalmology for Age-related Macular Degeneration Diseases Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Ophthalmology for Age-related Macular Degeneration Diseases Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Ophthalmology for Age-related Macular Degeneration Diseases Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Ophthalmology for Age-related Macular Degeneration Diseases
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size (M USD), 2019-2030
Figure 5. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size (M USD) (2019-2030)
Figure 6. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Ophthalmology for Age-related Macular Degeneration Diseases Market Size by Country (M USD)
Figure 11. Ophthalmology for Age-related Macular Degeneration Diseases Sales Share by Manufacturers in 2023
Figure 12. Global Ophthalmology for Age-related Macular Degeneration Diseases Revenue Share by Manufacturers in 2023
Figure 13. Ophthalmology for Age-related Macular Degeneration Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Ophthalmology for Age-related Macular Degeneration Diseases Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Ophthalmology for Age-related Macular Degeneration Diseases Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Share by Type
Figure 18. Sales Market Share of Ophthalmology for Age-related Macular Degeneration Diseases by Type (2019-2025)
Figure 19. Sales Market Share of Ophthalmology for Age-related Macular Degeneration Diseases by Type in 2023
Figure 20. Market Size Share of Ophthalmology for Age-related Macular Degeneration Diseases by Type (2019-2025)
Figure 21. Market Size Market Share of Ophthalmology for Age-related Macular Degeneration Diseases by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Share by Application
Figure 24. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Application (2019-2025)
Figure 25. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Application in 2023
Figure 26. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Share by Application (2019-2025)
Figure 27. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Share by Application in 2023
Figure 28. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Growth Rate by Application (2019-2025)
Figure 29. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Region (2019-2025)
Figure 30. North America Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Country in 2023
Figure 32. U.S. Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Ophthalmology for Age-related Macular Degeneration Diseases Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Ophthalmology for Age-related Macular Degeneration Diseases Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Country in 2023
Figure 37. Germany Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Region in 2023
Figure 44. China Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (K Units)
Figure 50. South America Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Country in 2023
Figure 51. Brazil Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Ophthalmology for Age-related Macular Degeneration Diseases Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Share Forecast by Type (2025-2030)
Figure 65. Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Forecast by Application (2025-2030)
Figure 66. Global Ophthalmology for Age-related Macular Degeneration Diseases Market Share Forecast by Application (2025-2030)
